Unlocking the Potential of CTAGE-9: A novel Drug Target and Biomarker

Target Name: CTAGE9

NCBI ID: G643854

CTAGE9

Unlocking the Potential of CTAGE-9: A novel Drug Target and Biomarker

CTAGE-9, short for CT-Agile Enrichment for Evolutionary Analysis 9, is a protein that is expressed in various tissues and cells of the human body. Its function is not well understood, but research has shown that it plays a crucial role in the regulation of cell adhesion, migration, and invasion. In recent years, the discovery of new drug targets and biomarkers has become an exciting trend in the pharmaceutical industry. CTAGE-9 has the potential to be a drug target and biomarker due to its unique structure and various functions.

The Protein CTAGE-9

CTAGE-9 is a 9 kDa protein that is expressed in various tissues and cells of the human body. It is characterized by a N-terminal extracellular domain (N-ED), a unique feature that is found in proteins that are involved in cell adhesion and migration. The N-ED is responsible for the protein's ability to interact with various cell adhesion molecules, including cadherins and integrins. This interaction is crucial for the protein's role in cell-cell adhesion and migration.

In addition to its N-ED, CTAGE-9 also has a unique C-terminus that is involved in various signaling pathways. This C-terminus is known as the N-terminal transmembrane region (N-TTR) and is responsible for the protein's ability to interact with various signaling molecules, including tyrosine kinases and G protein-coupled receptors. This interaction between the C-terminus and signaling molecules is important for the protein's role in cell signaling and regulation.

The Potential of CTAGE-9 as a Drug Target

The discovery of new drug targets is an exciting trend in the pharmaceutical industry. CTAGE-9 has the potential to be a drug target due to its unique structure and various functions.

One of the key reasons for the potential of CTAGE-9 as a drug target is its role in cell signaling and regulation. As previously mentioned, CTAGE-9 has a unique C-terminus that is involved in various signaling pathways. This C-terminus and its interaction with signaling molecules give the protein its ability to regulate cell signaling and cell-cell adhesion. This regulation is important for various cellular processes, including tissue repair, wound healing, and cell migration.

Another reason for the potential of CTAGE-9 as a drug target is its role in cancer progression. CTAGE-9 has been shown to be involved in various cellular processes that are associated with cancer progression, including the regulation of cell adhesion, migration, and invasion. This involvement in cancer progression makes CTAGE-9 an attractive drug target for cancer treatment.

The Potential of CTAGE-9 as a Biomarker

In addition to its potential as a drug target, CTAGE-9 also has the potential to be a biomarker. Biomarkers are proteins that are derived from biological sources, such as cells or tissues, and can be used to diagnose, monitor, or predict disease.

One of the key applications of CTAGE-9 as a biomarker is its ability to interact with various cell adhesion molecules. This interaction between CTAGE-9 and cell adhesion molecules is important for the protein's role in cell-cell adhesion and migration. This interaction can be used as a biomarker for various diseases, including cancer, where the regulation of cell adhesion and migration are disrupted.

Another application of CTAGE-9 as a biomarker is its ability to interact with various signaling molecules, including tyrosine kinases and G protein-coupled receptors. This interaction between CTAGE-9 and signaling molecules is important for the protein's role in cell signaling and regulation. This interaction

Protein Name: CTAGE Family Member 9

The "CTAGE9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTAGE9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets